Evidence map›Paper›PMID 30039154›Full record

ArticleAnnals of internal medicine2018

Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults.

Salomeh Keyhani, Stacey Steigerwald, Julie Ishida, Marzieh Vali, Magdalena Cerdá, Deborah Hasin, Camille Dollinger, Sodahm R Yoo, Beth E Cohen

Abstract read
In one paragraph

Article in Annals of internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 4 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 4 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis.Canadian journal of public health = Revue canadienne de sante publique · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Salomeh KeyhaniUniversity of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California (S.K., J.I., B.E.C.).
Stacey SteigerwaldNorthern California Institute for Research and Education, San Francisco, California (S.S., M.V., C.D., S.R.Y.).
Julie IshidaUniversity of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California (S.K., J.I., B.E.C.).
Marzieh ValiNorthern California Institute for Research and Education, San Francisco, California (S.S., M.V., C.D., S.R.Y.).
Magdalena CerdáUniversity of California, Davis, Davis, California (M.C.).
Deborah HasinColumbia University, New York, New York (D.H.).
Camille DollingerNorthern California Institute for Research and Education, San Francisco, California (S.S., M.V., C.D., S.R.Y.).
Sodahm R YooNorthern California Institute for Research and Education, San Francisco, California (S.S., M.V., C.D., S.R.Y.).
Beth E CohenUniversity of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California (S.K., J.I., B.E.C.).
Northern California Institute for Research and Education · USSan Francisco VA Medical Center · USColumbia University · USUniversity of California, Davis · USUniversity of California, San Francisco · US

Funding

Impact of marijuana on adherence, risk factor control and cardiovascular eventsR01HL130484 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2017 to 2020
$2.9M
Facilitating Appropriate Analgesic Prescription in Hemodialysis PatientsK23DK103963 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ISHIDA, JULIE · 2015 to 2018
$621k
NHLBI NIH HHS R01 HL130484NIDDK NIH HHS K23 DK103963
6 · The paper itself

Abstract

Background: Despite insufficient evidence regarding its risks and benefits, marijuana is increasingly available and is aggressively marketed to the public. Objective: To understand the public's views on the risks and benefits of marijuana use. Design: Probability-based online survey. Setting: United States, 2017. Participants: 16 280 U.S. adults. Measurements: Proportion of U.S. adults who agreed with a statement. Results: The response rate was 55.3% (n = 9003). Approximately 14.6% of U.S. adults reported using marijuana in the past year. About 81% of U.S. adults believe marijuana has at least 1 benefit, whereas 17% believe it has no benefit. The most common benefit cited was pain management (66%), followed by treatment of diseases, such as epilepsy and multiple sclerosis (48%), and relief from anxiety, stress, and depression (47%). About 91% of U.S. adults believe marijuana has at least 1 risk, whereas 9% believe it has no risks. The most common risk identified by the public was legal problems (51.8%), followed by addiction (50%) and impaired memory (42%). Among U.S. adults, 29.2% agree that smoking marijuana prevents health problems. About 18% believe exposure to secondhand marijuana smoke is somewhat or completely safe for adults, whereas 7.6% indicated that it is somewhat or completely safe for children. Of the respondents, 7.3% agree that marijuana use is somewhat or completely safe during pregnancy. About 22.4% of U.S. adults believe that marijuana is not at all addictive. Limitation: Wording of the questions may have affected interpretation. Conclusion: Americans' view of marijuana use is more favorable than existing evidence supports. Primary Funding Source: National Heart, Lung, and Blood Institute.

Indexed as

Attitude to HealthAdolescentAdultAgedAged, 80 and overAge FactorsAnxietyDepressionEpilepsyFemaleHumansMaleMarijuana AbuseMarijuana SmokingMiddle AgedMultiple SclerosisTobacco Smoke Pollution

Identifiers

PMID30039154
PMCPMC6157909
OpenAlexW2884057222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.